Publications by authors named "Pin-Nan Cheng"

Claim this Profile
A
Addition of neutrophil-to-lymphocyte ratio to Pre-DAA FIB-4 does not increase prediction value for de novo liver complications in hepatitis C.
Chun-Ming Hong, Tung-Hung Su, Shih-Jer Hsu, Tai-Chung Tseng, Chen-Hua Liu, Pin-Nan Cheng, Cheng-Yuan Peng

J Formos Med Assoc· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Refining Risk Estimates of Colorectal Cancer in Steatotic Liver Disease: Insights on Methodological Challenges.
Wei-Chun Cheng, Ching-Nung Wu, Pin-Nan Cheng

Clin Gastroenterol Hepatol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of Sofosbuvir/Velpatasvir Therapy on Extrahepatic Manifestations in Patients With Type 2 Diabetes and Chronic Hepatitis C: Insights From a Nationwide Hepatitis C Virus Registry in Taiwan.
Szu-Jen Wang, Te-Sheng Chang, Ching-Chu Lo, Chao-Hung Hung, Chien-Wei Huang, Pin-Nan Cheng, Cheng-Yuan Peng, Chien-Yu Cheng

Kaohsiung J Med Sci· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Survival impact of hepatitis C virus eradication in patients with or without active hepatocellular carcinoma: A nationwide cohort study.
Teng-Yu Lee, Sheng-Shun Yang, Pei-Chien Tsai, Chung-Feng Huang, Chi-Yi Chen, Pin-Nan Cheng, Cheng-Yuan Peng, Cheng-Hsin Chu

Eur J Cancer· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of HCV eradication by directly acting antivirals on glycemic indices in chronic hepatitis C patients -a nationwide Taiwan HCV registry.
Tyng-Yuan Jang, Chung-Feng Huang, Te-Sheng Chang, Chun-Chi Yang, Ching-Chu Lo, Pin-Nan Cheng, Cheng-Yuan Peng, Chien-Yu Cheng

J Formos Med Assoc· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of Hepatitis C Virus Clearance on Cardiovascular Risk: A Real-World Experience From the Nationwide Taiwan Hepatitis C Virus Registry.
Ping-Jen Hu, Pei-Chien Tsai, Chi-Yi Chen, Hsing-Tao Kuo, Chao-Hung Hung, Cheng-Yuan Peng, Cheng-Hsin Chu, Pin-Nan Cheng, Yen-Cheng Chiu, Jin-Shiung Cheng

Kaohsiung J Med Sci· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Direct-acting antiviral therapy for patients with hepatitis C virus-related hepatocellular carcinoma: A nationwide cohort study.
Shou-Wu Lee, Sheng-Shun Yang, Pei-Chien Tsai, Chung-Feng Huang, Chi-Yi Chen, Pin-Nan Cheng, Cheng-Yuan Peng, Cheng-Hsin Chu

Clin Mol Hepatol· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term risk of depression and the impact of risk factors among chronic hepatitis C patients after successful antiviral therapy: A nationwide real-world Taiwanese cohort (T-COACH).
Ping-Jen Hu, Ming-Lung Yu, Ming-Yao Chen, Chi-Yi Chen, Hsing-Tao Kuo, Cheng-Yuan Peng, Cheng-Hsin Chu, Pin-Nan Cheng, Yen-Cheng Chiu, Jin-Shiung Cheng

J Formos Med Assoc· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risk of de novo HCC in patients with MASLD following direct-acting antiviral-induced cure of HCV infection.
Chen-Hua Liu, Pin-Nan Cheng, Yu-Jen Fang, Chi-Yi Chen, Wei-Yu Kao, Cheng-Yuan Peng

J Hepatol· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Early antiviral treatment with tenofovir alafenamide to prevent serious clinical adverse events in adults with chronic hepatitis B and moderate or high viraemia (ATTENTION): interim results from a randomised controlled trial.
Young-Suk Lim, Ming-Lung Yu, Jonggi Choi, Chi-Yi Chen, Won-Mook Choi, Pin-Nan Cheng, Cheng-Yuan Peng

Lancet Gastroenterol Hepatol· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical Relevancies of Sarcopenic Obesity in Patients with Metabolic Dysfunction-Associated Fatty Liver Disease (MASLD).
Shih-Chieh Chien, Hung-Chih Chiu, Yen-Cheng Chiu, Ru-Hsueh Wang, Karl Paolo O Dillera, Pin-Nan Cheng

Dig Dis Sci· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-world efficacy and safety of universal 8-week glecaprevir/pibrentasvir in patients with chronic hepatitis C with early chronic kidney disease or pre-end-stage renal disease: Insights from a nationwide hepatisis C virus registry in Taiwan.
Szu-Jen Wang, Chung-Feng Huang, Te-Sheng Chang, Ching-Chu Lo, Chao-Hung Hung, Pin-Nan Cheng, Cheng-Yuan Peng, Chien-Yu Cheng

Kaohsiung J Med Sci· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High-normal and abnormal alanine transaminase levels linked to increased risk of hepatoma following treatment for chronic hepatitis C.
Yen-Chun Chen, Pei-Chien Tsai, Chung-Feng Huang, Chi-Yi Chen, Chao-Hung Hung, Pin-Nan Cheng, Cheng-Yuan Peng, Cheng-Hsin Chu

J Formos Med Assoc· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Posttreatment FIB-4 score change predicts hepatocellular carcinoma in chronic hepatitis C patients: Findings from the Taiwan hepatitis C registry program.
Hung-Wei Wang, Yu-Syuan Zeng, Chung-Feng Huang, Chi-Yi Chen, Hsing-Tao Kuo, Pin-Nan Cheng, Cheng-Hsin Chu, Cheng-Yuan Peng

J Formos Med Assoc· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical care guidance in patients with diabetes and metabolic dysfunction-associated steatotic liver disease: A joint consensus.
Jee-Fu Huang, Tien-Jyun Chang, Ming-Lun Yeh, Feng-Chih Shen, Chi-Ming Tai, Pin-Nan Cheng, Cheng-Yuan Peng

Hepatol Commun· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reply to correspondence on "Cardiovascular risk in chronic hepatitis B patients treated with tenofovir disoproxil fumarate or tenofovir alafenamide".
Pin-Nan Cheng, Ming-Lung Yu

Clin Mol Hepatol· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Benefits of Hepatitis C Viral Eradication: A Real-World Nationwide Cohort Study in Taiwan.
Chin-Wei Chang, Wei-Fan Hsu, Kuo-Chih Tseng, Chi-Yi Chen, Pin-Nan Cheng, Chien-Yu Cheng, Cheng-Yuan Peng

Dig Dis Sci· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dynamic change of metabolic dysfunction-associated steatotic liver disease in patients with hepatitis C virus infection after achieving sustained virologic response with direct-acting antivirals.
Chen-Hua Liu, Yu-Ping Chang, Yu-Jen Fang, Pin-Nan Cheng, Chi-Yi Chen, Cheng-Yuan Peng

J Gastroenterol· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multicenter evaluation of the safety and efficacy of selective internal radiation therapy with yttrium-90 resin microspheres in Taiwan: data from the RESIN registry.
Rheun-Chuan Lee, Po-Chin Liang, Huei-Lung Liang, Yung-Fang Chen, Chun-Yen Yu, Pin-Nan Cheng, Cheng-Yuan Hsia, Yu-Fan Cheng

J Gastroenterol Hepatol· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Metformin and statins reduce hepatocellular carcinoma risk in chronic hepatitis C patients with failed antiviral therapy.
Pei-Chien Tsai, Chung-Feng Huang, Ming-Lun Yeh, Meng-Hsuan Hsieh, Hsing-Tao Kuo, Cheng-Yuan Peng, Cheng-Hsin Chu, Pin-Nan Cheng, Yen-Cheng Chiu, Jin-Shiung Cheng

Clin Mol Hepatol· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-World Efficacy and Safety of Universal 8-Week Glecaprevir/Pibrentasvir for Treatment-Naïve Patients from a Nationwide HCV Registry in Taiwan.
Chun-Chi Yang, Chung-Feng Huang, Te-Sheng Chang, Ching-Chu Lo, Chao-Hung Hung, Pin-Nan Cheng, Cheng-Yuan Peng, Chien-Yu Cheng

Infect Dis Ther· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An algorithm for simplified hepatitis C virus treatment with non-specialist care based on nation-wide data from Taiwan.
Ming-Lung Yu, Chi-Ming Tai, Lein-Ray Mo, Hsing-Tao Kuo, Chung-Feng Huang, Pin-Nan Cheng, Chien-Yu Cheng, Cheng-Yuan Peng

Hepatol Int· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cardiovascular risk of tenofovir disoproxil fumarate or tenofovir alafenamide in patients with chronic hepatitis B: More questions than an answer.
Pin-Nan Cheng, Ming-Lung Yu

Clin Mol Hepatol· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Non-linear association between long-term air pollution exposure and risk of metabolic dysfunction-associated steatotic liver disease.
Wei-Chun Cheng, Pei-Yi Wong, Chih-Da Wu, Pin-Nan Cheng, Pei-Chen Lee

Environ Health Prev Med· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Artificial intelligence predicts direct-acting antivirals failure among hepatitis C virus patients: A nationwide hepatitis C virus registry program.
Ming-Ying Lu, Chung-Feng Huang, Chao-Hung Hung, Chi-Ming Tai, Lein-Ray Mo, Pin-Nan Cheng, Chien-Yu Cheng, Cheng-Yuan Peng

Clin Mol Hepatol· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis